Team:HKUST/Part1

From 2009.igem.org

(Difference between revisions)
 
(10 intermediate revisions not shown)
Line 18: Line 18:
<li><a href="https://2009.igem.org/Team:HKUST">Home</a></li>
<li><a href="https://2009.igem.org/Team:HKUST">Home</a></li>
<li><a href="https://2009.igem.org/Team:HKUST/Team">Our Team</a></li>
<li><a href="https://2009.igem.org/Team:HKUST/Team">Our Team</a></li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Project">Project description</a></li>
+
<li><a href="https://2009.igem.org/Team:HKUST/Project">Project Description</a></li>
-
<li> Odorant sensoring </a></li>
+
<b>
-
<li><a href="https://2009.igem.org/Team:HKUST/View1">Overview</a></li>
+
<span style="color:green">
-
<li><a href="https://2009.igem.org/Team:HKUST/Back1">Background</a></li>
+
<li>Main Parts</li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Group1">Experimental design</a></li>
+
</span>
-
<li><a href="https://2009.igem.org/Team:HKUST/Part1">Parts design</a></li>
+
</b>
-
<li><a href="https://2009.igem.org/Team:HKUST/Result1">Experimental result</a></li>
+
<li><a href="https://2009.igem.org/Team:HKUST/OdorantSensing">Odorant Sensing</a></li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Future1">Future work</a></li>
+
<li><a href="https://2009.igem.org/Team:HKUST/AttractantProduction">Attractant Production</a></li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Ref1">Reference</a></li>
+
<li><a href="https://2009.igem.org/Team:HKUST/ToxinProduction">Toxin Production</a></li>
-
+
-
<li> Attranctant production</a></li>
+
-
<li><a href="https://2009.igem.org/Team:HKUST/View3">Overview</a></li>
+
-
<li><a href="https://2009.igem.org/Team:HKUST/Back3">Background</a></li>
+
-
<li><a href="https://2009.igem.org/Team:HKUST/Group3">Experimental design</a></li>
+
-
<li><a href="https://2009.igem.org/Team:HKUST/Part3">Parts design</a></li>
+
-
<li><a href="https://2009.igem.org/Team:HKUST/Result3">Experimental result</a></li>
+
-
<li><a href="https://2009.igem.org/Team:HKUST/Future3">Future work</a></li>
+
-
<li><a href="https://2009.igem.org/Team:HKUST/Ref3">Reference</a></li>
+
-
<li>Toxin production</a></li>
+
<b>
-
<li><a href="https://2009.igem.org/Team:HKUST/View4">Overview</a></li>
+
<span style="color:green">
-
<li><a href="https://2009.igem.org/Team:HKUST/Back4">Background</a></li>
+
<li>Resources</li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Group4">Experimental design</a></li>
+
</span>
-
<li><a href="https://2009.igem.org/Team:HKUST/Part4">Parts design</a></li>
+
</b>
-
<li><a href="https://2009.igem.org/Team:HKUST/Result4">Experimental result</a></li>
+
-
<li><a href="https://2009.igem.org/Team:HKUST/Future4">Future work</a></li>
+
-
<li><a href="https://2009.igem.org/Team:HKUST/Ref4">Reference</a></li>
+
-
<li>Resources</a></li>
 
<li><a href="https://2009.igem.org/Team:HKUST/Lab Notebook">Lab Notebook</a></li>
<li><a href="https://2009.igem.org/Team:HKUST/Lab Notebook">Lab Notebook</a></li>
<li><a href="https://2009.igem.org/Team:HKUST/Parts">Parts Submitted </a></li>
<li><a href="https://2009.igem.org/Team:HKUST/Parts">Parts Submitted </a></li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Protocols">Protocol list</a></li>
+
<li><a href="https://2009.igem.org/Team:HKUST/Protocols">Protocol List</a></li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Resourses">Other resources</a></li>
+
<li><a href="https://2009.igem.org/Team:HKUST/Resourses">Other Resources</a></li>
</ul>
</ul>
</div>
</div>
Line 57: Line 44:
<ul>
<ul>
<li><a href="https://2009.igem.org/Team:Gallery">Gallery</a></li>
<li><a href="https://2009.igem.org/Team:Gallery">Gallery</a></li>
-
<li><a href="https://2009.igem.org/Team:Consolidation">Consolidation</a></li>
+
<li><a href="https://2009.igem.org/Team:Biosafety">Biosafety</a></li>
<li><a href="https://2009.igem.org/Team:Acknowledgement">Acknowledgement</a></li>
<li><a href="https://2009.igem.org/Team:Acknowledgement">Acknowledgement</a></li>
</ul>
</ul>
Line 63: Line 50:
</div>
</div>
<div id="rightxx">
<div id="rightxx">
-
<div class="contentxx">
+
<div class="contentodS_p"> <h3>a</h3>
-
<h3>Welcome</h3>
+
</div>
-
+
<div class="contentxx">
<p>Chimeric Receptor Construction</p>
<p>Chimeric Receptor Construction</p>
-
The chimeric receptor expression cassette contains the N- and C- terminals of the rat OR RI7, flanking the TM2-TM7 ligand-binding domain of the C. elegans OR Odr-10. The receptor sequence is first derived through fusion PCR, and then cloned into the yeast expression vector pESC-His for further localization and functional assay. </p>
+
The chimeric receptor expression cassette contains the N- and C- terminals of the rat OR RI7, flanking the TM2-TM7 ligand-binding domain of the <em>C. elegans</em> OR ODR-10. The receptor sequence is first derived through fusion PCR, and then cloned into the yeast expression vector pESC-His for further localization and functional assay. </p>
-
 
+
<br><br>
-
I. Primer Design</p>
+
<b>I. Primer Design</b></p><br><br>
-
We have designed several sets of primers for parts and BioBrick construction and DNA sequencing. The primer sequences are listed in Table 1. Primer statistics are calculated using NetPrimer. <br>
+
We have designed several sets of primers for parts and BioBrick construction and DNA sequencing. The primer sequences are listed in Table 1. Primer statistics are calculated using NetPrimer. <br><br>
-
For the chimeric receptor, primers are designed with 10 bp overlapping overhangs at the fusion junctions so that the fragments can anneal in fusion PCR. Two different reverse primers have been designed for the RI7 scaffold primers, one with stop codon incorporated into the sequence, and the other without. These two different alternatives can be chosen for construction of receptors with or without localization tags. In addition, nucleotide sequence in the primers has been modified in a few places to adjust for codon bias among C.elegans, rat and budding yeast. </p>
+
For the chimeric receptor, primers are designed with 10 bp overlapping overhangs at the fusion junctions so that the fragments can anneal in fusion PCR. Two different reverse primers have been designed for the RI7 scaffold primers, one with stop codon incorporated into the sequence, and the other without. These two different alternatives can be chosen for construction of receptors with or without localization tags. In addition, nucleotide sequence in the primers has been modified in a few places to adjust for codon bias among <em>C.elegans</em>, rat and budding yeast. </p><br><br>
-
The following diagram illustrates the schematic of the main primer design for the chimeric receptor. <br>
+
The following diagram illustrates the schematic of the main primer design for the chimeric receptor. <br><br>
-
<a href="http://www.freewebsitetemplates.com"><img src="http://igem2009hkust.fileave.com/wiki/Group1/Gp1 Fusion design.jpg " width=550; height=200 /></a>
+
<img src="http://igem2009hkust.fileave.com/wiki/Group1/figure10.jpg " width=569; height=184 /></p>
-
  Fig 7. Schematic diagram showing the primer design for the fusion receptor. </p>
+
<br>
-
 
+
<br>
-
Table 1  Primer sequences designed for the constructions<br>
+
<img src="http://igem2009hkust.fileave.com/wiki/Group1/figure11.jpg " width=600; height=450 />
-
*Note: <br>
+
</p>
-
1. Restriction sites are highlighted in blue. <br>
+
<br><br>
-
2. Overhangs for fusion junctions are highlighted in red. </p>
+
<b>II. PCR</b></p><br><br>
-
 
+
The DNA fragments coding for the RI7 localization scaffold and the ODR-10 ligand-binding pocket are first amplified separately from respective cDNA template (pHeI4 for RI7 and pPD9S.77 for ODR-10) via PCR. These fragments are then fused together via fusion PCR. <br><br>
-
II. PCR</p>
+
  In fusion PCR, reaction conditions and reactant concentrations must be carefully controlled to obtain satisfactory yields. DNA fragment fusion must be carried out in a stepwise process, by fusing RI7-N and ODR-10 first (using P1 and P5), followed by annealing this fused sequence to the RI7-C fragment (using P1 and P2). PCR cleanup is essential in the procedures, preferably by gel purification, since residual primers may affect the reaction in the next step, leading to amplification of the original template instead of desired fusion reaction. <br><br>
-
The DNA fragments coding for the RI7 localization scaffold and the Odr-10 ligand-binding pocket are first amplified separately from respective cDNA template (pHeI4 for RI7 and pPD9S.77 for Odr-10) via PCR. These fragments are then fused together via fusion PCR. <br>
+
-
  In fusion PCR, reaction conditions and reactant concentrations must be carefully controlled to obtain satisfactory yields. DNA fragment fusion must be carried out in a stepwise process, by fusing RI7-N and Odr-10 first (using P1 and P5), followed by annealing this fused sequence to the RI7-C fragment (using P1 and P2). PCR cleanup is essential in the procedures, preferably by gel purification, since residual primers may affect the reaction in the next step, leading to amplification of the original template instead of desired fusion reaction. <br>
+
  In the reaction, the two fragment templates are allowed to go through 1 to 2 PCR cycles without primers in order to create a fused template for amplification. The amplification primers are then added to the reaction mixture to allow for amplification of the whole fused sequence. <br>
  In the reaction, the two fragment templates are allowed to go through 1 to 2 PCR cycles without primers in order to create a fused template for amplification. The amplification primers are then added to the reaction mixture to allow for amplification of the whole fused sequence. <br>
 +
<br><br>
 +
<b>III. Cloning</b></p><br><br>
 +
After the chimeric receptor sequence is successfully derived through fusion PCR, standard cloning procedures are followed to construct a receptor expression cassette. <br><br>
 +
The pESC yeast epitope tagging vector pESC-HIS is used in the expression cassette construction. The chimeric receptor insert is cloned into MCS1 of the vector (under GAL10 promoter; with FLAG epitope tag) between the restriction sites EcoRI and NotI. The RI7 control construct can also be generated in the same way. <br><br>
 +
A GFP-tagged receptor can be generated by cloning the GFP tag into a constructed receptor expression vector, between the MCS1 sites of SpeI and SacI, replacing the FLAG epitope (Figure 9). <br><br>
-
III. Cloning</p>
+
<img src="http://igem2009hkust.fileave.com/wiki/Group1/figure12.jpg " width=600; height=350 />  
-
After the chimeric receptor sequence is successfully derived through fusion PCR, standard cloning procedures are followed to construct a receptor expression cassette. <br>
+
<br>
-
The pESC yeast epitope tagging vector pESC-HIS is used in the expression cassette construction. The chimeric receptor insert is cloned into MCS1 of the vector (under GAL10 promoter; with FLAG epitope tag) between the restriction sites EcoRI and NotI. The RI7 control construct can also be generated in the same way. <br>
+
-
A GFP-tagged receptor can be generated by cloning the GFP tag into a constructed receptor expression vector, between the MCS1 sites of SpeI and SacI, replacing the FLAG epitope (Figure 9). <br>
+
-
+
-
Fig 9. Map for pESC-HIS vector and its multiple cloning sites. <br>
+
-
 
+
 +
<br>
 +
<br>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Back1">Background</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Group1">Experimental Design</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Part1">Parts Design</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Result1">Experimental Results</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Future1">Future Work</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Ref1">References</a></li>
Line 112: Line 105:
<span> iGEM 2009 <br /> </span>  
<span> iGEM 2009 <br /> </span>  
</div>
</div>
-
<div id="payment"><img src="http://igem2009hkust.fileave.com/wiki/template/12092009/images/HKUSTLogo.jpg" alt="paypal" /></div>
+
<div id="payment"><img src="http://igem2009hkust.fileave.com/wiki/template/12092009/images/HKUSTLogo.jpg" alt="HKUST" /></div>
</div>
</div>
<div id="footerend"></div>
<div id="footerend"></div>

Latest revision as of 20:28, 21 October 2009

Salt and Soap template

a

Chimeric Receptor Construction

The chimeric receptor expression cassette contains the N- and C- terminals of the rat OR RI7, flanking the TM2-TM7 ligand-binding domain of the C. elegans OR ODR-10. The receptor sequence is first derived through fusion PCR, and then cloned into the yeast expression vector pESC-His for further localization and functional assay.



I. Primer Design



We have designed several sets of primers for parts and BioBrick construction and DNA sequencing. The primer sequences are listed in Table 1. Primer statistics are calculated using NetPrimer.

For the chimeric receptor, primers are designed with 10 bp overlapping overhangs at the fusion junctions so that the fragments can anneal in fusion PCR. Two different reverse primers have been designed for the RI7 scaffold primers, one with stop codon incorporated into the sequence, and the other without. These two different alternatives can be chosen for construction of receptors with or without localization tags. In addition, nucleotide sequence in the primers has been modified in a few places to adjust for codon bias among C.elegans, rat and budding yeast.



The following diagram illustrates the schematic of the main primer design for the chimeric receptor.





II. PCR



The DNA fragments coding for the RI7 localization scaffold and the ODR-10 ligand-binding pocket are first amplified separately from respective cDNA template (pHeI4 for RI7 and pPD9S.77 for ODR-10) via PCR. These fragments are then fused together via fusion PCR.

In fusion PCR, reaction conditions and reactant concentrations must be carefully controlled to obtain satisfactory yields. DNA fragment fusion must be carried out in a stepwise process, by fusing RI7-N and ODR-10 first (using P1 and P5), followed by annealing this fused sequence to the RI7-C fragment (using P1 and P2). PCR cleanup is essential in the procedures, preferably by gel purification, since residual primers may affect the reaction in the next step, leading to amplification of the original template instead of desired fusion reaction.

In the reaction, the two fragment templates are allowed to go through 1 to 2 PCR cycles without primers in order to create a fused template for amplification. The amplification primers are then added to the reaction mixture to allow for amplification of the whole fused sequence.


III. Cloning



After the chimeric receptor sequence is successfully derived through fusion PCR, standard cloning procedures are followed to construct a receptor expression cassette.

The pESC yeast epitope tagging vector pESC-HIS is used in the expression cassette construction. The chimeric receptor insert is cloned into MCS1 of the vector (under GAL10 promoter; with FLAG epitope tag) between the restriction sites EcoRI and NotI. The RI7 control construct can also be generated in the same way.

A GFP-tagged receptor can be generated by cloning the GFP tag into a constructed receptor expression vector, between the MCS1 sites of SpeI and SacI, replacing the FLAG epitope (Figure 9).




  • Background
  • Experimental Design
  • Parts Design
  • Experimental Results
  • Future Work
  • References
  • HKUST